We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.22B
AUM Growth
-$970M
Cap. Flow
-$969M
Cap. Flow %
-22.94%
Top 10 Hldgs %
17.21%
Holding
1,976
New
447
Increased
357
Reduced
374
Closed
503

Sector Composition

Rank Sector Weight
1 Healthcare 14.12%
2 Technology 11.17%
3 Industrials 6.47%
4 Consumer Discretionary 6.13%
5 Financials 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIS
1226
DELISTED
Tristar Acquisition I Corp.
TRIS
$197K ﹤0.01%
17,645
-19,626
-53% -$217K
EYE icon
1227
National Vision
EYE
$1.77B
$196K ﹤0.01%
15,000
-122,500
-89% -$2M
IVCPW
1228
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$196K ﹤0.01%
17,963
FUBO icon
1229
PUT
FuboTV Inc
FUBO
$261M
$196K ﹤0.01%
+13,183
New +$211K
ABR icon
1230
PUT
Arbor Realty Trust
ABR
$964M
$192K ﹤0.01%
+13,400
New +$179K
BCOV
1231
DELISTED
Brightcove, Inc.
BCOV
$191K ﹤0.01%
80,732
ZURAW
1232
DELISTED
Zura Bio Limited Warrants
ZURAW
$185K ﹤0.01%
+52,926
New +$26.8K
SLRN
1233
DELISTED
ACELYRIN
SLRN
$185K ﹤0.01%
41,986
-2,657
-6% -$12.5K
JBIO
1234
Jade Biosciences
JBIO
$1.2B
$183K ﹤0.01%
3,153
+358
+13% +$237K
SRTA
1235
Strata Critical Medical Inc
SRTA
$434M
$181K ﹤0.01%
+52,066
New +$174K
PRQR icon
1236
ProQR Therapeutics
PRQR
$243M
$177K ﹤0.01%
106,703
SSRM icon
1237
SSR Mining
SSRM
$5.32B
$176K ﹤0.01%
38,987
+3,623
+10% +$18.6K
AMBP icon
1238
Ardagh Metal Packaging
AMBP
$2.83B
$176K ﹤0.01%
+51,688
New +$194K
ABVEW
1239
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$171K ﹤0.01%
13,700
HUDAR
1240
DELISTED
Hudson Acquisition I Corp. Right
HUDAR
$170K ﹤0.01%
618,300
VGR
1241
DELISTED
Vector Group Ltd.
VGR
$169K ﹤0.01%
+16,022
New +$170K
CMPS
1242
CALL
Compass Pathways
CMPS
$1.53B
$169K ﹤0.01%
28,000
OSPN icon
1243
OneSpan
OSPN
$574M
$168K ﹤0.01%
13,110
-235,586
-95% -$2.83M
KVHI icon
1244
KVH Industries
KVHI
$181M
$165K ﹤0.01%
35,452
-13,068
-27% -$65.2K
MSAIW icon
1245
MultiSensor AI Holdings Warrant
MSAIW
$164K ﹤0.01%
100,000
AUGX
1246
DELISTED
Augmedix, Inc. Common Stock
AUGX
$163K ﹤0.01%
185,450
+33,686
+22% +$69.5K
AMLX icon
1247
Amylyx Pharmaceuticals
AMLX
$2.26B
$162K ﹤0.01%
85,477
-17,300
-17% -$33.5K
RAPT
1248
CALL
DELISTED
RAPT Therapeutics
RAPT
$162K ﹤0.01%
6,625
+3,737
+129% +$173K
PAGS icon
1249
PagSeguro Digital
PAGS
$2.69B
$159K ﹤0.01%
+13,563
New +$167K
ACEL icon
1250
Accel Entertainment
ACEL
$978M
$155K ﹤0.01%
+15,134
New +$160K

Similar funds

Boothbay Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, Boothbay Fund Management held 1,976 positions worth $4.22B, down 19% from $5.19B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management withdrew a net $969M in Q2 2024, closing 503 positions and reducing 374 holdings. Its most notable exit was Exact Sciences, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Boothbay Fund Management opened a new position in Sprott Physical Gold and Silver Trust worth $21.5M.

  • Boothbay Fund Management's largest Q2 2024 buy was Sprott Physical Gold and Silver Trust: 976,153 shares worth $21.5M.
  • Boothbay Fund Management added most to Apple in Q2 2024, an estimated $19.6M increase.
  • Boothbay Fund Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $62.1M.
  • Boothbay Fund Management fully exited Exact Sciences in Q2 2024, selling an estimated $22.8M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.22B portfolio in Q2 2024.
  • Boothbay Fund Management opened 447 new positions and closed 503 in Q2 2024.
  • Boothbay Fund Management's portfolio value fell 19% quarter-over-quarter to $4.22B.

Based on Boothbay Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.